DrugPipeline.net

Global Premature Ejaculation Treatment Market 2016-2020; New Report Launched

LogoPremature ejaculation refers to the discharge of semen shortly before or after penetration during sexual intercourse, thereby leading to an unsatisfactory sex life and affecting the patient's relationship with their partner. There is no proper cause that can be associated with the condition. However, personal distress and anxiety are possible attributes.

Global over-the-Counter Drug Market 2016-2020; New Report Launched

LogoOTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. These drugs are used to treat conditions that do not necessarily require a doctor's advice, such as pain, itches, cough and cold, sleeping problems, smoking cessation, weight problems, gastrointestinal problems, and tooth decay. They are sold through hospitals, pharmaceutical stores, grocery stores, catalogs, and online retail stores.

Myelofibrosis (MF)- Market Insights, Epidemiology and Market Forecast-2023; New Report Launched

LogoMyelofibrosis (MF) - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Myelofibrosis (MF) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Myelofibrosis (MF) till 2023.

Rheumatoid Arthritis (RA) - Market Insights, Epidemiology and Market Forecast-2023; New Report Launched

LogoRheumatoid Arthritis (RA) - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Rheumatoid Arthritis (RA) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Rheumatoid Arthritis (RA) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Rheumatoid Arthritis (RA) till 2023.

Syphilis - Market Insights, Epidemiology and Market Forecast-2023; New Report Launched

LogoSyphilis - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Syphilis for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Syphilis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Syphilis till 2023.

Dry Eye Disease- Market Insights, Epidemiology and Market Forecast-2023; New Report Launched

LogoDry eye disease - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Dry eye disease forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Dry eye disease till 2023.

Respiratory Syncytial Virus (RSV) - Market Insights, Epidemiology and Market Forecast-2023; New Report Launched

LogoRespiratory syncytial virus (RSV) - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Respiratory syncytial virus (RSV) for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Respiratory syncytial virus (RSV) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Respiratory syncytial virus (RSV) till 2023.

Polycystic Kidney Disease (PKD)- Market Insights, Epidemiology and Market Forecast-2023; New Report Launched

LogoPolycystic kidney disease (PKD) - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Polycystic kidney disease (PKD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Polycystic kidney disease (PKD) till 2023.

Duchenne Muscular Dystrophy - Market Insights, Epidemiology and Market Forecast-2023; New Report Launched

LogoDuchenne Muscular Dystrophy - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Duchenne Muscular Dystrophy for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Duchenne Muscular Dystrophy forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Duchenne Muscular Dystrophy till 2023.

Peripheral Arterial Disease - Market Insights, Epidemiology and Market Forecast-2023; New Report Launched

LogoPeripheral Arterial Disease - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Peripheral Arterial Disease for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Peripheral Arterial Disease forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Peripheral Arterial Disease till 2023.